| http://www.w3.org/ns/prov#value | - Paired serum samples were obtained from the 20 patients before treatment and after 6 months of treatment with DMARDs and/or infliximab. (A) Fifteen patients achieved at least an ACR20 response. ...DiscussionIn this study, we have found for the first time that serum FSTL1 levels are significantly elevated in patients with systemic autoimmune diseases, including RA, UC, SLE, SS, SSc and PM/DM. Furth
|
